Use of combination therapy in the routine care of patients with rheumatoid arthritis: Physician and patient surveys

Clinical and Experimental Rheumatology

Volumn 17, Issue 6 SUPPL. 18, 1999, Pages

  Hawley, D J ^a,c   Wolfe, F ^a,d   Pincus, T ^b  

^a NATIONAL DATA BANK FOR RHEUMATIC DISEASES   (United States)

^b VANDERBILT UNIVERSITY   (United States)

^c WICHITA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

Author keywords

Combination therapy; Hydroxychloroquine; Methotrexate; Rheumatoid arthritis

Indexed keywords

ANTIRHEUMATIC AGENT; HYDROXYCHLOROQUINE; METHOTREXATE; SALAZOSULFAPYRIDINE;

ARTICLE; CLINICAL PRACTICE; HUMAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; RHEUMATOID ARTHRITIS;

ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; MIDDLE AGED; QUESTIONNAIRES;

EID: 0032745848     PISSN: 0392856X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. MCCARTY DJ: Suppress rheumatoid arthritis early and leave the pyramid to the Egyptians. J Rheumatol 1990; 17: 1115-8.
2. WILKE WS, SWEENEY TH, CALABRESE LH: Early, agressive therapy for rheumatoid arthritis - Concerns, descriptions, and estimate of outcome. Semin Arthritis Rheum 1993; 23; 26-41.
3. PINCUS T: Aggressive treatment of early rheumatoid arthritis to prevent joint damage. Bull Rheum Dis 1998; 47: 2-7.
4. PAULUS HE: The use of combinations of disease-modifying antirheumatic agents in rheumatoid arthritis. Arthritis Rheum 1990; 33: 113-20.
5. FELSON DT, ANDERSON JJ, MEENAN RF: The efficacy and toxicity of combination therapy in rheumatoid arthritis - A meta-analysis. Arthritis Rheum 1994; 37: 1487-91.
6. VERHOEVEN AC, BOERS M, TUGWELL P: Combination therapy in rheumatoid arthritis: Updated systematic review. Br J Rheumatol 1998; 37: 612-9.
7. BOERS M, RAMSDEN M: Long acting drug combinations in rheumatoid arthritis: A formal overview. J Rheumatol 1991; 18: 316-24.
8. TUGWELL P, BOERS M: Long-acting drug combinations in rheumatoid arthritis: Updated review. In WOLFE F and PINCUS T (Eds.): Rheumatoid Arthritis: Pathogenesis, Assessment, Outcome, and Treatment. New York: Marcel Dekker; 1994; 16, p. 357-72.
9. BOERS M, VERHOEVEN AC, MARKUSSE HM et al.: Randomised comparison of combined step-down prednisolone, methotrexate and sulphasalazine with sulphasalazine alone in early rheumatoid arthritis. Lancet 1997; 350: 309-18.
10. O'DELL JR, HAIRE CE, ERIKSON N et al.: Treatment of rheumatoid arthritis with methotrexate alone, sulfasalazine and hydroxychloroquine, or a combination of all three medications. N Engl J Med 1996; 334: 1287-91.
11. VAN GESTEL AM, PREVOO ML, VAN 'T HOF MA, VAN RIJSWIJK MH, VAN DE PUTTE LBA, VAN RIEL PL: Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum 1996; 39: 34-40.
12. TUGWELL P, PINCUS T, YOCUM D et al.: Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. N Engl J Med 1995; 333: 137-41.
13. CORKILL MM, KIRKHAM BW, CHIKANZA IC, GIBSON T, PANAYI GS: Intramuscular depot methylprednisolone induction of chrysotherapy in rheumatoid arthritis: A 24-week randomized controlled trial. Br J Rheumatol 1990; 29: 274-9.
14. BENDIX G, BJELLE A: Adding low-dose cyclosporin A to parenteral gold therapy in rheumatoid arthritis: A double-blind placebo-controlled study. Br J Rheumatol 1996; 35: 1142-9.
15. CICONELLI RM, FERRAZ MB, VISIONI RA, OLIVEIRA LM, ATRA E: A randomized double-blind controlled trial of sulphasalazine combined with pulses of methylprednisolone or placebo in the treatment of rheumatoid arthritis. Br J Rheumatol 1996; 35: 150-4.
16. FAARVANG KL, EGSMOSE C, KRYGER P, PODENPHANT J, INGEMAN-NIELSEN M, HANSEN TM: Hydroxychloroquine and sulphasalazine alone and in combination in rheumatoid arthritis: A randomised double blind trial. Ann Rheum Dis 1993; 52: 711-5.
17. GIBSON T, EMERY P, ARMSTRONG RD, CRISP AJ, PANAYI GS: Combined D-penicillamine and chloroquine treatment of rheumatoid arthritis - A comparative study. Br J Rheumatol 1987; 26: 279-84.
18. HAAGSMA CJ, VAN RIEL PLCM, DEJONG AJL, VAN DE PUTTE LBA: Combination of sulphasalazine and methotrexate versus the single components in early rheumatoid arthritis: A randomized, controlled, double-blind, 52 week clinical trial. Br J Rheumatol 1997; 36: 1082-8.
19. HAAR D, SOLVKJAER M, UNGER B, RASMUSSEN KJ, CHRISTENSEN L, HANSEN TM: A double-blind comparative study of hydroxychloroquine and dapsone, alone and in combination, in rheumatoid arthritis. Scand J Rheumatol 1993; 22: 113-8.
20. MORELAND LW, SEWELL KL, TRENTHAM DE et al.: Interleukin-2 diphtheria fusion protein (DAB(486)IL-2) in refractory rheumatoid arthritis: A double-blind, placebo-controlled trial with open-label extension. Arthritis Rheum 1995; 38: 1177-86.
21. PORTER DR, CAPELL HA, HUNTER J: Combination therapy in rheumatoid arthritis - No benefit of addition of hydroxychloroquine to patients with a suboptimal response to intramuscular gold therapy. J Rheumatol 1993; 20: 645-9.
22. WILLIAMS HJ, WARD JR, READING JC et al.: Comparison of auranofin, methotrexate, and the combination of both in the treatment of rheumatoid arthritis. A controlled clinical trial [see comments]. Arthritis Rheum 1992; 35: 259-69.
23. WILLKENS RF, WILLIAMS HJ, WARD JR et al.: Randomized, double-blind, placebo controlled trial of low-dose pulse methotrexate in psoriatic arthritis. Arthritis Rheum 1984; 27: 376-81.
24. FERRAZ MB, PINHEIRO GRC, HELFENSTEIN M et al.: Combination therapy with methotrexale and chloroquine in rheumatoid arthritis - A multicenter randomized placebo-controlled trial. Scand J Rheumalol 1994; 23: 231-6.
25. SCOTT DL, DAWES PT, TUNN E et al.: Combination therapy with gold and hydoxychloroquine in rheumatoid arthritis: A prospective, randomized, placebo-controlled study. Br J Rheumatol 1989; 28: 128-33.
26. TRNAVSKY K, GATTEROVA J, LINDUSKOVA M, PELISKOVA Z: Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol 1993; 52: 292-6.
27. YASUDA M, SAKAI K, ORIBE M et al.: Efficacy of additive DMARD therapy in patients with rheumatoid arthritis. Double blind controlled trial using bucillamine and placebo with maintenance doses of gold sodium thiomalate. J Rheumatol 1994; 21: 44-50.
28. WEINBLATT ME, KREMER JM, BANKHURST AD et al.: A trial of etanercept, a recombinant tumor necrosis factor receptor: Fc fusion protein, in patients with rheumatoid arthritis receiving methotrexate. N Engl J Med 1999; 340: 253-9.
29. SMOLEN JS, KALDEN JR, SCOTT DL et al.: Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: A double-blind, randomised, multicentre trial. Lancet 1999; 353: 259-66.
30. MORELAND LW, BAUMGARTNER SW, SCHIFF MH et al.: Treatment of rheumatoid arthritis with a recombinant human tumor necrosis factor receptor (p75)-Fc fusion protein. N Engl J Med 1997; 337: 141-7.
31. CAMPION GV, LEBSACK ME, LOOKABAUGH J et al.: Dose-range and dose-frequency study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis. Arthritis Rheum 1996; 39: 1092-101.
32. MAINI RN, BREEDVELD FC, KALDEN JR et al.: Therapeutic efficacy of multiple intravenous infusions of anti-tumor necrosis factor alpha monoclonal antibody combined with low-dose weekly methotrexate in rheumatoid arthritis. Arthritis Rheum 1998; 41: 1552-63.
33. WOLFE F, ALBERT DA, PINCUS T: A survey of United States rheumatologists concerning effectiveness of disease-modifying antirheumatic drugs and prednisone in the treatment of rheumatoid arthritis. Arthritis Care Res 1998; 11: 375-81.
34. MAETZEL A, BOMBARDIER C, STRAND V, TUGWELL P, WELLS G: How Canadian and US rheumatologists treat moderate or aggressive rheumatoid arthritis: A survey. J Rheumatol 1998; 25: 2331-8.
35. MORELAND LW, KIMBERLY RP, ALARCON GS: European (EU) and US rheumatologists (RHEUM) agree on triple therapy but not on double or single early DMARD choices for different types of RA. [Abstract] Arthritis Rheum 1997; 40 (Suppl.): S218.
36. O'DELL JR: Combination DMARD therapy for rheumatoid arthritis: Apparent universal acceptance. [Abstract] Arthritis Rheum 1997; 40 (Suppl.): S50.
37. BROOKS P: Recent advances in rheumatology. Br Med J 1998; 316: 1810-2.
38. BELLAMY N, BROOKS PM: Current practice in antimalarial drug prescribing in rheumatoid arthritis. J Rheumatol 1986; 13: 551-5.
39. WOLFE F, HAWLEY DJ, PINCUS T: Disease-modifying anti-rheumatic drugs (DMARD) and DMARD combination used by 3604 patients of 303 US rheumatologists. [Abstract] Arthritis Rheum 1999 (Suppl.), in press.
40. WARD MM, FRIES JE: Trends in antirheumatic medication use among patients with rheumatoid arthritis, 1981-1996. J Rheumatol 1998; 25: 408-16.
41. OWEN SG, FRIESEN WT, ROBERTS MS, FRANCIS H, FLUX W: Functional capacity and treatment data from a community based study of patients with rheumatoid arthritis. Ann Rheum Dis 1986; 45: 293-303.
42. The North American Rheumatoid Arthritis Disease Management Study Group: Selection of DMARD therapy in early rheumatoid arthritis. [Abstract] Arthritis Rheum 1998; 41 (Suppl.): S269.
43. WOLFE F, PINCUS T, FRIES JF et al.: Use of second line "disease modifying" anti-rheumatic drugs (DMARDs) within 3 months of disease onset by 64% of 750 rheumatoid arthritis patients under care of 142 US rheumatologists: An inception cohort study. [Abstract] Arthritis Rheum 1997; 40 (Suppl.): S218.
44. ILLEI G, ARAYSSI T, YARBORO C et al.: Treatment patterns of early rheumatoid arthritis. [Abstract] Arthritis Rheum 1997; 40 (Suppl.): S96.
45. International Rheumatoid Arthritis Disease Management Group: Management of rheumatoid arthritis: Database comparison of academic vs. community and Canadian experience. [Abstract] Arthritis Rheum 1997; 40 (Suppl.): S218.
46. NOWLIN NS, KRELING D, DELL CL et al.: DMARDS in the nineties: The UW experience. [Abstract] Arthritis Rheum 1998; 41 (Suppl.): S153.
47. PAL B, AMLESH H: Combination treatment is rare in patients with rheumatoid arthritis. Br Med J 1998; 317: 1653-4.
48. WANG B, BALISE R, FRIES JF: Frequency of two-DMARD combinations in the treatment of rheumatoid arthritis (RA). [Abstract] Arthritis Rheum 1998; 41 (Suppl.): S59.